124 related articles for article (PubMed ID: 12217610)
1. Positive octreotide scan in a case of hepatocellular carcinoma.
Schommartz B; Brill N; Larisch R; Wettstein M; Häussinger D; Müller-Gärtner HW
J Hepatol; 2002 Oct; 37(4):539. PubMed ID: 12217610
[No Abstract] [Full Text] [Related]
2. Somatostatin analogs and hepatocellular carcinoma: Not dead yet?
Raftery L; O'Neil BH
Cancer Biol Ther; 2009 Nov; 8(21):2040-1. PubMed ID: 19823044
[No Abstract] [Full Text] [Related]
3. Octreotide scans are positive in a subset of patients with hepatocellular carcinoma.
Rabinowitz I; Telepak R; Lee FC
Clin Nucl Med; 2002 Jul; 27(7):499-502. PubMed ID: 12072777
[TBL] [Abstract][Full Text] [Related]
4. A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma.
Deming DA; Stella AL; Holen KD; Ku G; O'Reilly EM
Clin Adv Hematol Oncol; 2005 Jun; 3(6):468-72; discussion 472-4. PubMed ID: 16167024
[No Abstract] [Full Text] [Related]
5. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
[No Abstract] [Full Text] [Related]
6. The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
Dimitroulopoulos D; Xinopoulos D; Tsamakidis K; Zisimopoulos A; Andriotis E; Markidou S; Panagiotakos D; Chrysohoou C; Bazinis A; Paraskevas E
Hepatogastroenterology; 2002; 49(47):1245-50. PubMed ID: 12239914
[TBL] [Abstract][Full Text] [Related]
7. Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.
Senturk H; Canbakan B; Cumali R
J Gastroenterol Hepatol; 2004 Jun; 19(6):719-20. PubMed ID: 15151636
[No Abstract] [Full Text] [Related]
8. Dynamic hepatobiliary scan appearance of hepatocellular carcinoma.
Intenzo CM; Hendricks P; Kim S; Park CH
Clin Nucl Med; 1988 May; 13(5):325-6. PubMed ID: 2839314
[TBL] [Abstract][Full Text] [Related]
9. [6. Inspection of Hepatocellular Carcinoma 4: Nuclear Medicine Scan].
Odagiri H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jun; 72(6):522-9. PubMed ID: 27320156
[No Abstract] [Full Text] [Related]
10. [A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].
Allgaier HP; Becker G; Blum HE
Dtsch Med Wochenschr; 2000 Mar; 125(11):320. PubMed ID: 10761474
[No Abstract] [Full Text] [Related]
11. [Clinical significance of Tc99m colloid liver angiography for the diagnosis of hepatocellular carcinoma (author's transl)].
Odano I; Sakai K; Sueyama H
Kaku Igaku; 1982 Mar; 19(2):255-61. PubMed ID: 6287065
[No Abstract] [Full Text] [Related]
12. Chronic hypersensitivity pneumonitis with heart involvement observed during in-111 DTPA octreotide (OctreoScan) imaging.
Zanglis A; Andreopoulos D; Zissimopoulos A; Baziotis N
Clin Nucl Med; 2003 Dec; 28(12):994-5. PubMed ID: 14663328
[No Abstract] [Full Text] [Related]
13. [Computed tomography of the primary liver cancers (author's transl)].
Kobayashi T; Kusano S; Ishii K; Kan S; Horiike S; Ito K; Sakuma S; Tominaga S; Sawada T; Matsubayashi T; Atari H
Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Aug; 38(8):744-53. PubMed ID: 212711
[No Abstract] [Full Text] [Related]
14. Focal defect in a liver scintigram.
Lopez-Majano V; Fogelson L; Friedman F
Eur J Nucl Med; 1982; 7(10):482-3. PubMed ID: 6291948
[No Abstract] [Full Text] [Related]
15. Focal gallium uptake in the liver.
Winzelberg GG
Semin Nucl Med; 1984 Jan; 14(1):55-6. PubMed ID: 6324378
[No Abstract] [Full Text] [Related]
16. [Localization of technetium-99m methylene diphosphonate in hepatocellular carcinoma--a report of two cases].
Shirai S; Okinaga T; Dannoura R; Bussaka Y; Oshibuchi M; Kikuchi S; Morita S; Ohtake H
Kaku Igaku; 1985 Nov; 22(11):1721-5. PubMed ID: 3007824
[No Abstract] [Full Text] [Related]
17. [A case of hepatocellular carcinoma associated with autoimmune hepatitis and increased scintigraphy of liver accumulation].
Niki S; Haruyama K; Kokuno S; Itoi T; Mizoue T; Takei K; Mizumura Y; Sanada J; Mizuguchi Y; Ogihara S; Takeda K; Onoda K; Miwa K; Shinohara Y; Magami Y; Horibe T; Kakutani H; Niido T; Seki T; Hisa T; Saitou T
Nihon Shokakibyo Gakkai Zasshi; 1997 Mar; 94(3):220-4. PubMed ID: 9095644
[No Abstract] [Full Text] [Related]
18. Hepatic scintigraphy in the evaluation of solitary solid liver masses.
Rubin RA; Lichtenstein GR
J Nucl Med; 1993 Apr; 34(4):697-705. PubMed ID: 8384256
[No Abstract] [Full Text] [Related]
19. Octreotide treatment of hepatocellular carcinoma.
Kouroumalis E; Samonakis D; Skordilis P
Hepatology; 2003 Feb; 37(2):477. PubMed ID: 12540801
[No Abstract] [Full Text] [Related]
20. Imaging of somatostatin receptor subtype 2 in advanced hepatocellular carcinoma by 68Ga-DOTATOC PET.
Freesmeyer M; Schulz S; Knösel T; Settmacher U
Nuklearmedizin; 2009; 48(3):N17-8. PubMed ID: 19588574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
